Antiretroviral Therapy Access
Cross-source consensus on Antiretroviral Therapy Access from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Benefits
Risks & contraindications
Other
Highlighted claims
- The study evaluated whether COVID-19 disrupted access to antiretroviral therapy for adults living with HIV. — Effect of COVID-19 pandemic on ART access and timely initiation in people living with HIV in 31 countries: a regression discontinuity design study
- The primary outcome was weekly ART initiations among people presenting for first-time HIV clinic care. — Effect of COVID-19 pandemic on ART access and timely initiation in people living with HIV in 31 countries: a regression discontinuity design study
- Six countries experienced statistically significant decreases in weekly ART initiation counts during the pandemic period. — Effect of COVID-19 pandemic on ART access and timely initiation in people living with HIV in 31 countries: a regression discontinuity design study
- Weekly ART initiation counts remained stable in most of the included countries. — Effect of COVID-19 pandemic on ART access and timely initiation in people living with HIV in 31 countries: a regression discontinuity design study